Asgarova et al.[11] have shown that PD‐L1 expression is increased by NF‐κB pathway activation and that tumor hypoxia and inflammation induced by HIF‐1α and GLUT‐1 often mediate tumor progression and cause PD‐L1 elevation. Here, NFKB1 is linked to neoplasm.